However, since all these biomarkers have potential of detecting early HCC, further studies in Sub-Saharan Africa are required to assess whether their sensitivity and specificity can even be increased when combined with AFP and an abdominal ultrasound scan. The gene discussed is AFP; the disease is hepatocellular carcinoma.